How do highly expanded clones carrying #HIV infectious proviruses survive despite strong immune pressure?
We had blast working side by side with the Blankson Lab. Here is a "short"🧵on our last story published in @jclinicalinvest, led by @filippdragon1 and @abena_kwaa
Can’t believe tomorrow is my PhD graduation from @JohnsHopkins! This Hispanic/Latino from Puerto Rico 🇵🇷 is honored to have been selected as Commencement Speaker by popular vote to represent all graduates 🤩 Grandpa, I wish you could be here to see your dream realized 👴🏻🕊️
Check out our new story in which we dive into the depths of non-suppressible viremia (NSV) despite effective ART. 📈https://t.co/tDG18Fw4G3
We investigated plasma HIV-1 RNA in 4 people on ART and found that 5'-Leader defective proviruses can cause NSV. A short🧵.
I am delighted to share I was selected for the @NIHDirector’s Early Independence Award (DP5)😱, allowing me to launch my research program @HopkinsMedicine and contribute to a better understanding of #HIV persistence. Thank you @NIH_CommonFund!
Disappointing trial readout for the HIV community. I’m hopeful new technology and persistence of the scientific community will help us reach the goal of eradicating HIV! We have an imperative to keep moving forward quickly
#GlympseBio CEO @CarolineLoew spoke with the @HopkinsBioPod about our biosensors for disease detection and monitoring and her work developing Glympse from its beginnings.
Listen: https://t.co/cuhItoBRKg
As an expert in toxicology, I can say that drug testing should never be used to determine if one is violating the “spirit of the sport,” whatever that is.